Get Social With Us

Evaluating Strategic Options for Biomanufacturing: Build vs. Buy vs. Acquire

Presented at: IBC Biopharmaceutical Manufacturing and Development Summit Orlando, Florida, December 5-6, 2006

This presentation reviews the many factors that must be considered in developing a comprehensive manufacturing strategy against the backdrop of the current industry-wide supply and demand situation for biomanufacturing capacity. In addition to suitability and availability of contract manufacturing capacity, biopharmaceutical firms must consider the strategic importance of establishing internal manufacturing capacity, the risks associated with both internal and external manufacturing options, and of course financial considerations.